Wholomics developed a novel multi-cancer early detection test that is quick, easy, and more accurate than any other screening approach on the market. Our tests are designed to detect the presence of cancer markers in the blood, allowing early detection of a multitude of cancer types. With our novel biology-backed approach we bring state-of-the-art technologies in combination with AI straight to the patients.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Ried Im Innkreis
- Industry
- Medical And Diagnostic Laboratories
- NAICS
-
Medical and Diagnostic LaboratoriesMedical LaboratoriesDiagnostic Imaging Centers
- Website
- https://www.wholomics.com
- Keywords
- Cancer, Diagnostics, Early Detection, Health Tech, Multi-Cancer Early Detection, Liquid Biopsy, Krebs, Krebsfrüherkennung, Diagnostik, Cancer Test.
- HQ
- Ried im Innkreis
Wholomics Questions
Wholomics's website is https://www.wholomics.com
Wholomics's LinkedIn profile is https://at.linkedin.com/company/wholomics
Wholomics has
3 employees.
View email and phone details for 3
employees at Wholomics.
Wholomics's industry is
Medical and Diagnostic Laboratories
Wholomics's top competitors are
Cellectric Biosciences,
Cellon,
Brightmind.ai,
Ablevia Biotech Gmbh,
Sendance,
Emotional Data Extension,
Rockfish Bio,
Robotdreams® Gmbh,
Brightcomsol,
Miphic (Techstars'24).
Wholomics's categories are Medical and Diagnostic Laboratories
Wholomics's founding year is 2022
